MX2007008662A - Analogos macrociclicos para el tratamiento de trastornos inmunorreguladores y enfermedades respiratorias. - Google Patents

Analogos macrociclicos para el tratamiento de trastornos inmunorreguladores y enfermedades respiratorias.

Info

Publication number
MX2007008662A
MX2007008662A MX2007008662A MX2007008662A MX2007008662A MX 2007008662 A MX2007008662 A MX 2007008662A MX 2007008662 A MX2007008662 A MX 2007008662A MX 2007008662 A MX2007008662 A MX 2007008662A MX 2007008662 A MX2007008662 A MX 2007008662A
Authority
MX
Mexico
Prior art keywords
alkyl
optionally substituted
compound
mmol
compound according
Prior art date
Application number
MX2007008662A
Other languages
English (en)
Spanish (es)
Inventor
Kevin Hunter
Stephen Schlachter
John Gaudino
Laurence Burgess
Original Assignee
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc filed Critical Array Biopharma Inc
Publication of MX2007008662A publication Critical patent/MX2007008662A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007008662A 2005-01-20 2006-01-19 Analogos macrociclicos para el tratamiento de trastornos inmunorreguladores y enfermedades respiratorias. MX2007008662A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64555205P 2005-01-20 2005-01-20
PCT/US2006/001747 WO2006078724A2 (en) 2005-01-20 2006-01-19 Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases

Publications (1)

Publication Number Publication Date
MX2007008662A true MX2007008662A (es) 2007-09-06

Family

ID=36692822

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007008662A MX2007008662A (es) 2005-01-20 2006-01-19 Analogos macrociclicos para el tratamiento de trastornos inmunorreguladores y enfermedades respiratorias.

Country Status (8)

Country Link
US (1) US7553842B2 (cg-RX-API-DMAC10.html)
EP (1) EP1838316A4 (cg-RX-API-DMAC10.html)
JP (1) JP2008528491A (cg-RX-API-DMAC10.html)
AU (1) AU2006206525A1 (cg-RX-API-DMAC10.html)
CA (1) CA2601380A1 (cg-RX-API-DMAC10.html)
MX (1) MX2007008662A (cg-RX-API-DMAC10.html)
TW (1) TW200637552A (cg-RX-API-DMAC10.html)
WO (1) WO2006078724A2 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0904540D0 (en) * 2009-03-17 2009-04-29 Biotica Tech Ltd Novel compounds and methods for their production
GB0917817D0 (en) * 2009-10-12 2009-11-25 Biotica Tech Ltd Novel compounds and methods for their production
GB0917816D0 (en) * 2009-10-12 2009-11-25 Biotica Tech Ltd Novel compounds and methods for their production
IT1401451B1 (it) * 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
US9814703B2 (en) 2013-11-14 2017-11-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating cancer by activation of BMP signaling
EP3433259B1 (en) * 2016-03-24 2021-06-30 The Administrators of The Tulane Educational Fund Conjugates of tacrolimus, their compositions, and their uses
CA3043575A1 (en) * 2016-11-10 2018-05-17 Novartis Ag Bmp potentiators
CN108148032B (zh) * 2018-03-01 2019-12-13 北京海步医药科技股份有限公司 一种3,4-二氢-2h-1-苯并吡喃-2-羧酸类化合物的制备方法及其应用
CN119751235A (zh) * 2019-01-23 2025-04-04 约翰霍普金斯大学 非免疫抑制性fk506类似物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2245891A (en) 1990-07-09 1992-01-15 Fujisawa Pharmaceutical Co Tricyclo compounds
US5565560A (en) 1991-05-13 1996-10-15 Merck & Co., Inc. O-Aryl,O-alkyl,O-alkenyl and O-alkynylmacrolides having immunosuppressive activity
US5457111A (en) * 1991-09-05 1995-10-10 Abbott Laboratories Macrocyclic immunomodulators
US5563172A (en) * 1991-09-05 1996-10-08 Abbott Laboratories Macrocyclic amide and urea immunomodulators
US5252732A (en) * 1991-09-09 1993-10-12 Merck & Co., Inc. D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity
US5284877A (en) * 1992-06-12 1994-02-08 Merck & Co., Inc. Alkyl and alkenyl macrolides having immunosuppressive activity
WO1994021634A1 (en) * 1993-03-17 1994-09-29 Abbott Laboratories Substituted alicyclic-aliphatic amine-containing macrocyclic immunomodulators
US5457194A (en) * 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
WO1994021254A1 (en) * 1993-03-17 1994-09-29 Abbott Laboratories Substituted alicyclic amine-containing macrocyclic immunomodulators
WO1994021642A1 (en) * 1993-03-17 1994-09-29 Abbott Laboratories Macrocyclic amide and urea immunomodulators
US6093615A (en) * 1994-08-15 2000-07-25 Micron Technology, Inc. Method of fabricating a contact structure having a composite barrier layer between a platinum layer and a polysilicon plug
DE19859467C2 (de) * 1998-12-22 2002-11-28 Steag Micro Tech Gmbh Substrathalter
US6569867B2 (en) * 1999-10-01 2003-05-27 Kosan Biosciences, Inc. Polyketide derivatives

Also Published As

Publication number Publication date
AU2006206525A2 (en) 2006-07-27
TW200637552A (en) 2006-11-01
AU2006206525A1 (en) 2006-07-27
EP1838316A4 (en) 2012-01-25
WO2006078724A3 (en) 2008-01-24
US20060160838A1 (en) 2006-07-20
EP1838316A2 (en) 2007-10-03
US7553842B2 (en) 2009-06-30
JP2008528491A (ja) 2008-07-31
WO2006078724A2 (en) 2006-07-27
CA2601380A1 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
EP3893871B1 (en) Benzimidazolone derivatives, and analogues thereof, as il-17 modulators
EP3638227B1 (en) Spirocyclic indolines as il-17 modulators
EP2170863B1 (en) Pyrimido cyclopentanes useful for the treatment of inflammatory or hyperproliferative diseases
CA2771484C (en) Substituted benzoazepines as toll-like receptor modulators
EP2240494B1 (en) Thieno-pyridine derivatives as mek inhibitors
EP2401269B1 (en) Indole derivatives as crth2 receptor antagonists
EP3426244B1 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
US8921363B2 (en) Derivatives of 1 H-isoindol-3-amine, 1 H-iso-aza-indol-3amine, 3,4-dihydroisoquinolin-1-amine, and 1,4-dihydroisoquinolin-3-amine as beta-secretase inhibitors
AU2024216533A1 (en) Processes of making and crystalline forms of a MDM2 inhibitor
EP3884939B1 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
CN101351466A (zh) Janus激酶3的杂环抑制剂
EP1307457A1 (fr) Composes azabicycliques, leur preparation et leur utilisation comme medicaments , notamment comme anti-bacteriens
JP2011522843A (ja) 新規なカリウムチャンネルブロッカー及びその使用
US5604234A (en) Substituted thiol macrolactam immunomodulators
US8921550B2 (en) Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
US8822485B2 (en) Amino heteroaryl compounds as beta-secretase modulators and methods of use
US7226906B2 (en) Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
US7553842B2 (en) Macrocyclic analogs for the treatment of immunoregulatory disorders and respiratory diseases
WO2025165806A1 (en) Dipeptidyl peptidase 1 inhibitors and uses thereof
WO2017075341A1 (en) Fused imidazole derivatives as ido/tdo inhibitors
EP3551632B1 (en) Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors
US20060035821A1 (en) Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
CN117447460A (zh) 作为ripk1抑制剂的杂环化合物
WO1999067239A1 (en) Pyrazolopyridine compounds and medicinal uses thereof
HK1160465B (en) Indole derivatives as crth2 receptor antagonists

Legal Events

Date Code Title Description
FA Abandonment or withdrawal